Key participants include AbbVie, Inc., Celgene, Bayer AG, Bristol Myers Squibb and Company, Epizyme Inc.,

According to the current analysis of Emergen research, the global Follicular lymphoma treatment market was valued at USD 2.08 billion in 2019 and is expected to reach USD 3.73 billion by 2027, at a CAGR of 7.6%